Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Research Collaboration Consortium (RCC) is a specialized clinical research site network and contract research organization (CRO) that facilitates the execution of Phase I-IV clinical trials. The organization partners with pharmaceutical, biotechnology, and medical device companies to provide high-quality data and patient recruitment services across a variety of therapeutic areas. RCC operates a network of integrated research sites, offering centralized management, standardized operating procedures, and expertise in complex trial protocols. Their services include site selection, patient enrollment, study coordination, and regulatory compliance management. The consortium is particularly recognized for its work in cardiovascular and metabolic research, often collaborating with major global pharmaceutical sponsors to advance new therapies through the clinical development lifecycle.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Research Collaboration Consortium.